Varian Medical Shares Quiet Following News of FDA 510(K) Clearance for RapidPlan

Varian Medical Systems

today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a radiotherapy treatment planning tool designed to enhance quality, consistency, and efficiency in radiotherapy treatment planning.    Showcased for the first time at the annual meeting of the American Society for Radiation Oncology (ASTRO) in Atlanta last month, RapidPlan opens the door to enhanced treatment planning by providing clinics with knowledge-based models that generate high-quality personalized treatment plans for their patients.